XML 43 R23.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Plans
6 Months Ended
Jun. 30, 2019
Stock Plans [Abstract]  
Stock Plans (15) Stock Plans:

At June 30, 2019, we have seven stock-based compensation plans under which grants were made and awards remained outstanding. No further awards may be granted under six of the plans: the 1996 Equity Incentive Plan (the 1996 EIP), the Amended and Restated 2000 Equity Incentive Plan (the 2000 EIP), the 2009 Equity Incentive Plan (the 2009 EIP), the 2013 Equity Incentive Plan (the 2013 EIP), the Deferred Fee Plan and the Directors’ Equity Plan. At June 30, 2019, there were approximately 5,667,000 shares authorized for grant and approximately 2,797,000 shares available for grant under the 2017 Equity Incentive Plan (the 2017 EIP and together with the 1996 EIP, the 2000 EIP, the 2009 EIP and the 2013 EIPS, the EIPs).

Performance Shares

As of January 1, 2019, we had 497,000 outstanding performance shares under the Frontier Long Term Incentive Plan (the LTIP). The following summary presents information regarding LTIP target performance shares as of June 30, 2019 and changes during the six months then ended with regard to LTIP shares awarded under the 2013 EIP and the 2017 EIP:

  

 Number of

Shares

(in thousands)

Balance at January 1, 2019

497

LTIP target performance shares granted, net

-

LTIP target performance shares earned

(41)

LTIP target performance shares forfeited

(20)

Balance at June 30, 2019

436

  

For purposes of determining compensation expense, the fair value of each performance share is measured at the end of each reporting period and, therefore, will fluctuate based on the price of Frontier common stock as well as performance relative to the targets. For the six months ended June 30, 2019 and 2018, we recognized net compensation expense, reflected in “Selling, general and administrative expenses,” of $1 million and $2 million, respectively, for the LTIP.

Restricted Stock

The following summary presents information regarding unvested restricted stock as of June 30, 2019 and changes during the six months then ended with regard to restricted stock granted under the 2013 EIP and the 2017 EIP:

Weighted

Average

Number of

Grant Date

Aggregate

Shares

Fair Value

Fair Value

(in thousands)

(per share)

(in millions)

Balance at January 1, 2019

1,858

$

16.02

$

4

Restricted stock granted

105

$

2.00

$

-

Restricted stock vested

(701)

$

21.99

$

(1)

Restricted stock forfeited

(18)

$

30.37

Balance at June 30, 2019

1,244

$

11.28

$

2

For purposes of determining compensation expense, the fair value of each restricted stock grant is estimated based on the closing price of a share of our common stock on the date of the grant. Total remaining unrecognized compensation cost associated with unvested restricted stock awards that is deferred at June 30, 2019 was $10 million, and the weighted average vesting period over which this cost is expected to be recognized is approximately 1 year.

Shares of restricted stock granted during the first six months of 2018 totaled 1,996,000 shares. The total fair value of shares of restricted stock granted at June 30, 2018 was approximately $11 million. The total fair value of unvested restricted stock at June 30, 2018 was $11 million. The weighted average grant date fair value of restricted shares granted during the six months ended June 30, 2018 was $8.30 per share.

We have granted restricted stock awards to employees in the form of our common stock. None of the restricted stock awards may be sold, assigned, pledged or otherwise transferred, voluntarily or involuntarily, by the employees until the restrictions lapse, subject to limited exceptions. The restrictions are time-based. Compensation expense, recognized in “Selling, general and administrative expenses,” of $5 million and $7 million for the six month periods ended June 30, 2019 and 2018, respectively, has been recorded in connection with these grants.